Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myelomeningocele: early-phase trial registry
5 of 9 indexed Myelomeningocele trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Myelomeningocele: 9 US clinical trials tracked, 5 recruiting.
Myelomeningocele is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The University of Texas Health Science Center, Houston, running 2 of these trials.
Enrollment posture brief
Registry condition myelomeningocele
OPEN 5 | RECR 56% | LATE 0 | EARLY 1 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)
Myelomeningocele lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myelomeningocele on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myelomeningocele is recruiting above its size-band peers.
5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Myelomeningocele research.
The University of Texas Health Science Center, Houston accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Myelomeningocele trials plan to enrol fewer than 100 people.
Median target enrolment is 55 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.
-
Myelomeningocele research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
In-Utero Endoscopic Correction of Spina Bifida
University of Southern California
NCT04362592
Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair
The University of Texas Health Science Center, Houston
NCT06042140
Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial
University of California, Davis
NCT04652908
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
Mayo Clinic
NCT06918119
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
USFetus
NCT03856034
Sleep-disordered Breathing in Infants With Myelomeningocele
University of Michigan
NCT04251806
Incontinence and Quality of Life in Children With Spina Bifida
Indiana University
NCT03410667
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
The University of Texas Health Science Center, Houston
NCT04243889
Fetoscopic Repair of Isolated Fetal Spina Bifida
Johns Hopkins University
NCT03090633
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Myelomeningocele records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myelomeningocele trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myelomeningocele page
9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Myelomeningocele trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The University of Texas Health Science Center, Houston sponsors the most Myelomeningocele trials on record, review their full trial history before evaluating a specific study. See The University of Texas Health Science Center, Houston's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myelomeningocele condition card totals 9 registered trials; most-linked intervention Fetoscopy; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.